These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 7685835)
1. Cisplatin, vindesine, pepleomycin and combined radiation therapy for inoperable esophageal carcinoma. Saito T; Kinoshita T; Shigemitsu Y; Shimoda K; Katsuta T; Miyahara M; Kobayashi M; Ashizawa A Jpn J Clin Oncol; 1993 Apr; 23(2):123-9. PubMed ID: 7685835 [TBL] [Abstract][Full Text] [Related]
2. Extended survival time for esophageal cancer patients treated with aggressive surgery and concurrent chemoradiation. Saito T; Shigemitsu Y; Kinoshita T; Shimoda K; Katsuta T; Abe T; Chikuba K; Miyahara M; Kobayashi M Int Surg; 1994; 79(2):93-7. PubMed ID: 7928159 [TBL] [Abstract][Full Text] [Related]
3. [Combined chemoradio (CVPR) therapy in the treatment of inoperable and recurrent esophageal cancer]. Saito T; Zeze K; Shigemitsu Y; Kuwahara A; Miyahara M; Shimoda K; Kobayashi M Nihon Gan Chiryo Gakkai Shi; 1988 Jun; 23(6):1283-9. PubMed ID: 2466097 [No Abstract] [Full Text] [Related]
4. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179 [TBL] [Abstract][Full Text] [Related]
5. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery. Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576 [TBL] [Abstract][Full Text] [Related]
6. [Radiotherapy combined with S-1 and cisplatin for locally advanced and metastatic esophageal cancer]. Iwase H Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():224-9. PubMed ID: 16898007 [TBL] [Abstract][Full Text] [Related]
7. Accelerated-interrupted radiation therapy given concurrently with chemotherapy for locally advanced non-small cell lung cancer. Ajlouni M; Chapman R; Kim JH Cancer J Sci Am; 1996; 2(6):314-20. PubMed ID: 9166551 [TBL] [Abstract][Full Text] [Related]
8. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study. Baldini E; Silvano G; Tibaldi C; Campoccia S; Cionini L; Conte P Semin Oncol; 2000 Feb; 27(1 Suppl 1):28-32. PubMed ID: 10697041 [TBL] [Abstract][Full Text] [Related]
9. Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma. Hejna M; Kornek GV; Schratter-Sehn AU; Zach M; Schoder M; Raderer M; Rosen H; Schiessel R; Scheithauer W Cancer; 1996 Oct; 78(8):1646-50. PubMed ID: 8859175 [TBL] [Abstract][Full Text] [Related]
10. [The combined radiochemotherapy of inoperable esophageal neoplasms: a feasibility study]. Sola B; Airoldi M; Orecchia R; Rovea P; Fracchia F; Boidi Trotti A; Tessa M; Foco A; Oliaro A; Casadio C; Dei Poli M Radiol Med; 1996 Apr; 91(4):456-9. PubMed ID: 8643859 [TBL] [Abstract][Full Text] [Related]
11. Selective dose escalation of chemoradiotherapy for esophageal cancer: role of treatment intensification. Seung SK; Smith JW; Molendyk J; Bader SB; Phillips M; Regan J; Louie J; Soo E; Seligman M; Ruzich J; Skokan L; Ross HJ Semin Oncol; 2004 Dec; 31(6 Suppl 18):13-9. PubMed ID: 15726517 [TBL] [Abstract][Full Text] [Related]
12. Cisplatin, vindesine, pepleomycin and concurrent radiation therapy following esophagectomy with lymph adenectomy for patients with an esophageal carcinoma. Saito T; Shigemitsu Y; Kinoshita T; Shimoda K; Abe T; Nakamura A; Chikuba K; Kobayashi M Oncology; 1993; 50(4):293-7. PubMed ID: 7684520 [TBL] [Abstract][Full Text] [Related]
13. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial. Chen GY; Jiang GL; Wang LJ; Qian H; Fu XL; Yang H; Wu KL; Zhao S Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):70-5. PubMed ID: 15629596 [TBL] [Abstract][Full Text] [Related]
14. [Radiotherapy combined with pepleomycin administration for the treatment of esophageal cancer]. Koyama S; Togo J; Miyamoto J; Nakahara A; Kawakita I; Shibata H; Yamagata S; Muto H; Fukutomi H; Sakita T; Ohara K; Akisada M Gan To Kagaku Ryoho; 1982 Sep; 9(9):1562-7. PubMed ID: 6191719 [TBL] [Abstract][Full Text] [Related]
15. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study. Choi N; Park SD; Lynch T; Wright C; Ancukiewicz M; Wain J; Donahue D; Mathisen D Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):111-22. PubMed ID: 15337546 [TBL] [Abstract][Full Text] [Related]
16. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy. Weiner LM; Colarusso P; Goldberg M; Dresler C; Coia LR Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276 [TBL] [Abstract][Full Text] [Related]
17. [Concurrent concentrated radio-chemotherapy of epidermoid cancer of the esophagus. Long-term results of a phase II national multicenter trial in 122 non-operable patients (FFCD 8803)]. Seitz JF; Milan C; Giovannini M; Dumas F; Cauvin JM; Conroy T; François E; Renard P; Votte-Lambert A; Paillot B; Bedenne L; ; Gastroenterol Clin Biol; 2000 Feb; 24(2):201-10. PubMed ID: 12687962 [TBL] [Abstract][Full Text] [Related]
18. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report. Gaspar LE; Winter K; Kocha WI; Coia LR; Herskovic A; Graham M Cancer; 2000 Mar; 88(5):988-95. PubMed ID: 10699886 [TBL] [Abstract][Full Text] [Related]